Michel Dahan, COO of Akebia Therapeutics AKBA, has filed 0 purchases and 8 sales on the open market. The latest trade was on 24/05/13.

MD

MD

Michel Dahan

SVP, COO

Company

Akebia Therapeutics AKBA

First filing

23/03/03

Trades

13 trades

Buys / sales

0 / 8

12-month net buying

No record

Last trade

24/05/13

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Akebia TherapeuticsAKBA	Open-market sale10b5-1 plan	24/05/13	24/05/14	34,840 sh	$1.26	$43,898.4	−4.9%
Akebia TherapeuticsAKBA	Open-market sale	24/02/29	24/03/01	8,661 sh	$1.58	$13,684.38	−1.2%
Akebia TherapeuticsAKBA	Open-market sale	24/02/27	24/02/29	10,744 sh	$1.52	$16,330.88	−1.5%
Akebia TherapeuticsAKBA	Open-market sale	23/05/25	23/05/25	95,478 sh	$1.22	$116,483.16	−14.3%
Akebia TherapeuticsAKBA	Open-market sale	23/03/01	23/03/03	20,412 sh3 trades	$0.88avg.	$17,962.56	−7.0%
Akebia TherapeuticsAKBA	Open-market sale	23/02/27	23/03/01	10,090 sh	$0.81	$8,172.9	−3.4%